Books in Immunology

101-110 of 660 results in All results

GPCR Signaling in Cancer

1st Edition
Volume 145
February 20, 2020
Arun K. Shukla
English
Hardback
9 7 8 - 0 - 1 2 - 8 2 0 2 3 0 - 2
eBook
9 7 8 - 0 - 1 2 - 8 2 0 2 3 1 - 9

GPCR Signaling in Cancer, Volume 145, the latest release in the Advances in Cancer Research series, highlights recent developments in the area of GPCRs and cancer biology. Chapters included in this volume cover several GPCRs and their downstream effectors as case examples to highlight their fundamental understanding and therapeutic potential. Specific chapters address the Role of GRKs and beta-arrestins in cancer, Atypical GPCRs in cancer, the Role of a chemokine receptor (CCR) 5 in cancer, Targeting G protein-coupled receptors for therapeutics in cancer, Emerging GPCR signaling pathways in cancer, and more. G protein-coupled receptors (GPCRs) constitute a large family of cell surface receptors which are involved in nearly every cellular and physiological event. These receptors can recognize a broad array of ligands and they are targeted by nearly one third of the currently prescribed drugs including anti-cancer therapeutics.

Advances in Immunology in China - Part B

1st Edition
Volume 145
February 18, 2020
Chen Dong + 1 more
English
Hardback
9 7 8 - 0 - 1 2 - 8 1 7 8 7 8 - 2
eBook
9 7 8 - 0 - 1 2 - 8 1 7 8 7 9 - 9

Advances in Immunology in China - Part B, Volume 145, the latest release in the Advances in Immunology series, presents the latest release in a long-established and highly respected publication. The book includes current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release focusing on advances in immunology in China.

Maternal Immunization

1st Edition
November 26, 2019
Elke Leuridan + 2 more
English
Paperback
9 7 8 - 0 - 1 2 - 8 1 4 5 8 2 - 1
eBook
9 7 8 - 0 - 1 2 - 8 1 4 5 8 3 - 8

Immunization during pregnancy with currently recommended vaccines prevents infection in the mother, the unborn fetus, and the young infant, and there is an increasing focus from different stakeholders to use this approach for other infections of importance to protect these vulnerable groups. The aim of this Maternal Immunization book is to provide a contemporary overview of vaccines used in pregnancy (and the lactation period), with emphasis on aspects of importance for the target groups, namely, rationale for the use of vaccines in pregnancy, safety, immunogenicity (immunology), timing to vaccinate, repeat doses, protective effects in the mother, fetus, and infant, and public acceptance and implementation, of existing and of future vaccines.

Innate Immunity

1st Edition
November 15, 2019
Yves Carton
English
Hardback
9 7 8 - 1 - 7 8 5 4 8 - 3 0 8 - 0
eBook
9 7 8 - 0 - 1 2 - 8 2 1 8 1 0 - 5

Innate immunity is a new branch of immunology, confirmed by three Nobel Prize winners in 2011. It is the first line of defense against pathogens and is in a way the preliminary step of adaptive immunity which occurs later, and only present in vertebrates. This book examines the way in which innate immunity was discovered in invertebrates. As a starting point, it looks at the work of Louis Pasteur on silkworm disease and the findings of Ilya Metchnikov, discoverer of phagocytosis. It also investigates André Paillot, who in 1920 demonstrated the existence of humoral immunity in insects, unrelated to the type of immunity that was initially thought to be present in all vertebrates. Finally, Innate Immunity shows how the group directed by Jules Hoffmann found strong similarities between the innate immunity response of insects and mammals. The discovery of a receptor protein in Drosophila, which is also found in humans, was what led to Jules Hoffmann being awarded the Nobel Prize in 2011.

Advances in Immunology in China - Part A

1st Edition
Volume 144
November 4, 2019
Chen Dong + 1 more
English
Hardback
9 7 8 - 0 - 1 2 - 8 1 7 7 0 8 - 2
eBook
9 7 8 - 0 - 1 2 - 8 1 7 7 0 9 - 9

Advances in Immunology in China - Part A, Volume 144, the latest release in the Advances in Immunology series, presents the latest release in a long-established and highly respected publication. The book includes current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release focusing on advances in immunology in China.

Mucosal Vaccines

1st Edition
October 18, 2019
David W. Pascual
English
Paperback
9 7 8 - 0 - 1 2 - 8 1 1 9 2 4 - 2
eBook
9 7 8 - 0 - 1 2 - 8 1 1 9 2 5 - 9

Mucosal Vaccines: Innovation for Preventing Infectious Diseases discusses basic knowledge and discovery in the area of mucosal immunology and its related scientific fields. This completely updated, revised and authoritative treatise covers all aspects of mucosal vaccines, including their development, mechanisms of action, molecular/cellular aspects and practical applications. The book is organized in a unique format with basic, clinical and practical aspects described and discussed. The accumulated knowledge and new discoveries on the development of mucosal vaccines are logically introduced and discussed in an easy-to-understand format.

The Autoimmune Diseases

6th Edition
October 15, 2019
M. Eric Gershwin + 1 more
English
Hardback
9 7 8 - 0 - 1 2 - 8 1 2 1 0 2 - 3
eBook
9 7 8 - 0 - 1 2 - 8 1 2 2 4 2 - 6

The Autoimmune Diseases, Sixth Edition, emphasizes the "3 P’s" of 21st Century medicine: precision, prediction and prevention. Topics cover the modern systems approach to biology that involves large amounts of personalized, ongoing physiologic data ("omics") coupled with advanced methods of analysis, new tests of genetic engineering, such as CRISPR, auto inflammatory diseases, autoimmune responses to tumor immunotherapy, and information on normal immune response and disorders. Each of the major autoimmune disorders is discussed by researchers and clinical investigators experienced in dealing with patients. Chapters emphasize the immunologic basis of the disease as well as the use of immunologic diagnostic methods and treatments. The book also covers several cross-cutting issues related to the recognition and treatment of autoimmune diseases, including chapters on the measurement of autoantibodies and T cells, the use of biomarkers as early predictors of disease, and new methods of treatment.

Advances in Immunology

1st Edition
Volume 143
October 11, 2019
Frederick W. Alt
English
Hardback
9 7 8 - 0 - 1 2 - 8 1 7 7 0 6 - 8
eBook
9 7 8 - 0 - 1 2 - 8 1 7 7 0 7 - 5

Advances in Immunology, Volume 143, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release focusing on the design of vaccine strategies to elicit HIV-1 broadly neutralizing antibodies, gender bias, fungi, fibrinolysis and allergic airway inflammation, updating and interpreting airway epithelial cell reprogramming in bronchial asthma, the link(s) of sensing to the immune response, and the regulatory role of the autonomic system.

Advances in Cancer Research

1st Edition
Volume 144
July 24, 2019
Paul B. Fisher + 1 more
English
Hardback
9 7 8 - 0 - 1 2 - 8 1 7 1 5 5 - 4
eBook
9 7 8 - 0 - 1 2 - 8 1 7 1 5 6 - 1

Advances in Cancer Research, Volume 144, the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research. Chapters in this new release include Gene-Environment-Microenvironment Interactions in Melanomagenesis, PP2A and the Cell Cycle, Current Progress Defining Calcium Signals as Therapeutic Targets in Cancer Cells, and much more.

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy

1st Edition
July 19, 2019
Mumtaz Y. Balkhi
English
Paperback
9 7 8 - 0 - 1 2 - 8 1 9 5 7 3 - 4
eBook
9 7 8 - 0 - 1 2 - 8 1 9 7 4 7 - 9

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant cancers. Recent clinical data obtained with checkpoint receptor blockade inhibitors and chimeric antigen receptor (CAR) therapy has been especially promising, thus generating renewed hope that we may be on the verge of finally curing cancer. Over the years, huge progress has been made in controlling several stage IV metastasized cancers through the clinical application of checkpoint receptor inhibitory drugs and CAR-Therapy that has seen unprecedented interest in the immunotherapy field.